Safety and efficacy of bronchial thermoplasty in Australia 5 years post-procedure

Background and Objective: Outside clinical trials, there is limited long-term data following bronchial thermoplasty (BT). In a cohort of real-world severe asthmatics in an era of biological therapy, we sought to evaluate the safety and efficacy of BT 5 years post-treatment. Methods: Every patient treated with BT at two Australian tertiary centres were recalled at 5 years, and evaluated by interview and record review, Asthma Control Questionnaire (ACQ), spirometry and high-resolution CT Chest. CT scans were interpreted using the modified Reiff and BRICS CT scoring systems for bronchiectasis. Results: Fifty-one patients were evaluated. At baseline, this cohort had a mean age of 59.0 +/- 11.8 years, mean ACQ of 3.0 +/- 1.0, mean FEV1 of 55.5 +/- 18.8% predicted, and 53% were receiving maintenance oral steroids in addition to triple inhaler therapy. At 5 years, there was a sustained improvement in ACQ scores to 1.8 +/- 1.0 (p < 0.001). Steroid requiring exacerbation frequency was reduced from 3.8 +/- 3.6 to 1.0 +/- 1.6 exacerbations per annum (p < 0.001). 44% of patients had been weaned off oral steroids. No change in spirometry was observed. CT scanning identified minor degrees of localized radiological bronchiectasis in 23/47 patients with the modified Reiff score increasing from 0.6 +/- 2.6 at baseline to 1.3 +/- 2.5 (p < 0.001). However, no patients exhibited clinical features of bronchiectasis, such as recurrent bacterial infection. Conclusion: Sustained clinical benefit from BT at 5 years was demonstrated in this cohort of very severe asthmatics. Mild, localized radiological bronchiectasis was identified in a portion of patients without clinical features of bronchiectasis.

Automated summary

In a cohort of severe asthmatics in the era of biological therapy, the safety and efficacy of bronchial thermoplasty (BT) was evaluated 5 years post-treatment. The results showed sustained improvement in symptoms control and reduced steroid requirement, but no change in spirometry. Mild localized radiological bronchiectasis was identified in some patients without clinical features.